Skip to main content

and
  1. No Access

    Article

    Reversing resistance to immune checkpoint inhibitor by adding recombinant human adenovirus type 5 in a patient with small cell lung cancer with promoted immune infiltration: a case report

    Small cell lung cancer (SCLC) is an aggressive malignancy with poor prognosis. Since immune checkpoint inhibitors (ICIs) have had significant benefits in SCLC, studying and overcoming the mechanisms of ICI res...

    Qi Zhao, **gzhi Tong, **aoqin Liu, Si Li in Journal of Cancer Research and Clinical On… (2022)

  2. Article

    Open Access

    Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients

    Although many of the recently approved genomically targeted therapies have improved outcomes for patients in non–small-cell lung cancer (NSCLC) with lung adenocarcinoma, little is known about the genomic alter...

    Liyun Miao, Yongsheng Wang, Suhua Zhu, Minke Shi, Yan Li, **g**g Ding in BMC Cancer (2014)

  3. No Access

    Article

    Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition

    Discoidin domain receptors (DDRs) are a novel class of receptor tyrosine kinases that respond to several collagens and facilitate cell adhesion. DDR1 is highly expressed in a variety of human cancers, and it i...

    Liyun Miao, Suhua Zhu, Yongsheng Wang, Yan Li, **g**g Ding in Medical Oncology (2013)